Related Experiment Videos
[Host factors in cancer chemotherapy]
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|April 1, 1986
Summary
Host factors like blood counts and tumor markers do not reliably predict chemotherapy response. Tumor regression remains the primary measure of treatment effectiveness in cancer patients.
Area of Science:
- Oncology
- Immunology
- Biochemistry
Context:
- Cancer progression is influenced by host-tumor interactions.
- Understanding host factors is crucial for predicting chemotherapy and immunotherapy outcomes.
- Reliable host factors could enable quantitative assessment of treatment efficacy.
Purpose:
- To investigate host factors, including complete blood counts (CBC), blood chemistries, tumor markers, and immunological parameters, in relation to cancer chemotherapy and immunotherapy effects.
- To determine if pretreatment levels or post-treatment changes in these host factors can reliably predict treatment response or evaluate therapeutic effects.
Summary:
- Researchers analyzed CBC, blood chemistries, tumor markers (e.g., AFP, CEA, CA 19-9), and immunological parameters (e.g., lymphocyte subsets, NK cell activity) in cancer patients undergoing chemotherapy/immunotherapy.
- No significant differences in pretreatment host factor levels were found between responders and non-responders.
- While responders showed some improvement in host factors post-treatment, these were not reliable predictors of therapeutic effects.
Impact:
- Current clinical evaluation of chemotherapy effectiveness relies on definitive tumor regression.
- This study highlights the limitations of using host factors as sole indicators of treatment success.
- Further research may be needed to identify more precise biomarkers for cancer treatment response.